SCHEMBL23360751

SCHEMBL23360751

COC(=O)N1CCc2cc[c]cc2C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.43
NR1H2 P55055 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ABHD6 Q9BV23 1/20 0.41
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
TAS1R2 Q8TE23 2/20 0.40
ESR2 Q92731 1/20 0.40
TAAR1 Q96RJ0 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
PRMT5 O14744 2/20 0.38
WDR77 Q9BQA1 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8013063 0.83 NOTUM (0.63) NOTUMNPC1RAB9ASMN1; SMN2TAS1R3
SCHEMBL1202085 0.80 ALDH1A1 (0.48) NOTUMSMN1; SMN2ESR2KMT2AMEN1
SCHEMBL30056523 0.80 NOTUM (0.67) NOTUMNPC1RAB9ASMN1; SMN2ABHD6
SCHEMBL464005 0.80 NOTUM (0.67) NOTUMNPC1RAB9ASMN1; SMN2ABHD6
SCHEMBL17005756 0.79 MEN1 (0.44) NOTUMNPC1RAB9ASMN1; SMN2TAAR1
SCHEMBL952312 0.79 ESR2 (0.62) NR1H2SMN1; SMN2ABHD6ESR2MAPT
SCHEMBL1202119 0.79 ABHD6 (0.47) NOTUMNR1H2ABHD6ESR2PRMT5
SCHEMBL6097273 0.77 NOTUM (0.58) NOTUMNPC1RAB9ASMN1; SMN2ABHD6
SCHEMBL3486703 0.77 NOTUM (0.63) NOTUMNPC1RAB9ASMN1; SMN2TAS1R3
SCHEMBL1201231 0.77 PRMT5 (0.41) NOTUMSMN1; SMN2ABHD6ESR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752492-B1 FUNGICIDAL OXADIAZOLES BAYER AG (DE) 2022-12-21 EP disclosed
US-20210147371-A1 OXADIAZOLINE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147371-A1 OXADIAZOLINE DERIVATIVES DDT, FOXO3, PDCD4 NOTUM 292/4885NR1H2 3799/4885NPC1 3922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.